Search
for
Sort by
Research 331–360 of 1000+
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Antiandrogenic activities of<i>Glycyrrhiza glabra</i>in male rats
- The evolution of primary multimodality treatment in resectable breast cancer
- Hair loss
- Loose anagen hair syndrome in children of Upper Egypt
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Controversies in plastic surgery: Suction-assisted lipectomy (SAL) and the hCG (human chorionic gonadotropin) protocol for obesity treatment
- Multiple minute digitate hyperkeratosis
- Hair loss
- Alopecia Induced by Timolol Eye-drops
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients
- Hair Transplant
- Adverse cutaneous effects of psychotropic medications
- Changes in murine hair with dietary selenium excess or deficiency
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- brief review on “Herbal Hair Tonic”
- Malignant epithelial tumors: Part II. Therapy and prevention
- Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials
- Cytokines
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- Establishment of a culture model for the prolonged maintenance of chicken feather follicles structure in vitro
- Cutaneous Reactions to Drugs
- Scalp Tourniquets for Chemotherapy-Induced Alopecia
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Dermatologic Adverse Events from Cancer Treatments
- Chemotherapy-Induced Alopecia
- Fractional erbium-doped yttrium aluminum garnet laser 2940 nm-assisted delivery of topical timolol solution for the treatment of histiocytoid hemangioma
- 129 Genetic transformation of keratoacanthoma-type cutaneous squamous cell carcinoma following intralesional chemotherapy
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy